An interaction between two proteins points to a molecular basis for memory. But how do memories last when the molecules that ...

Neurodegenerative diseases like Parkinson’s and Alzheimer’s affect millions of people and are becoming more common as the ...

The human brain comprises billions of neurons, synapses, and cell types, making it one of the universe's most intricate and ...

Psychedelics like ketamine and LSD straddle a fine line—offering therapeutic promise under medical supervision, yet posing ...

The endorsement means the EMA will offer Carthera support and advice as it moves towards a regulatory filing for its SonoCloud ultrasound system.

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

This study overall shows there is an interplay between the BBB and CB1 receptors on perivascular astrocytes that influences chronic stress resilience.

A common blood test can flag early Alzheimer's disease patients who are four times more likely to experience rapid brain decline, a new study says.

Explore new treatments for neurological diseases with Chiesi Group's latest enzyme replacement therapies for rare disorders.

Shuttle-based therapies are under active development for an array of brain conditions. “It’s now abundantly clear that we can get these drugs across the blood–brain barrier,” says Gorman.

They found that this enzyme is even further elevated in AD, traumatic brain injury and aging in both mice and humans, and that this change harms the BBB. New drug With 15-PGDH in the BBB as the focus, ...